Search research articles
Contact Us
Filters
Showing results (1-10 of 10) with videos related to
Page
of 1
Sort By:
Journal of Chemical Information and Modeling
|
April 6, 2005
2D-3D migration of large chemical inventories with conformational multiplication. Application of the genetic algorithm
Ovanes Mekenyan, Todor Pavlov, Vanjo Grancharov, et al.
Journal of Chemical Information and Modeling
|
May 1, 2007
Conformational coverage by a genetic algorithm: saturation of conformational space
Todor Pavlov, Milen Todorov, Galina Stoyanova, et al.
Chemical Research in Toxicology
|
December 7, 2007
Identifying the structural requirements for chromosomal aberration by incorporating molecular flexibility and metabolic activation of chemicals
Ovanes Mekenyan, Milen Todorov, Rossitsa Serafimova, et al.
Chemical Research in Toxicology
|
September 18, 2010
Use of genotoxicity information in the development of integrated testing strategies (ITS) for skin sensitization
Ovanes Mekenyan, Grace Patlewicz, Gergana Dimitrova, et al.
Toxicology in Vitro : an International Journal Published in Association with BIBRA
|
October 12, 2010
Development of a mechanistic SAR model for the detection of phototoxic chemicals and use in an integrated testing strategy
Stephanie Ringeissen, Laurent Marrot, Reine Note, et al.
Regulatory Toxicology and Pharmacology : RTP
|
March 21, 2015
A feasibility study: Can information collected to classify for mutagenicity be informative in predicting carcinogenicity?
Petko I Petkov, Grace Patlewicz, Terry W Schultz, et al.
Journal of Applied Toxicology : JAT
|
May 27, 2016
Integrated approach to testing and assessment for predicting rodent genotoxic carcinogenicity
Petko I Petkov, Terry W Schultz, E Maria Donner, et al.
Bioorganic & Medicinal Chemistry Letters
|
September 16, 2018
In vitro and in vivo characterization of a novel, highly potent p53-MDM2 inhibitor
Andrea Vaupel, Philipp Holzer, Stephane Ferretti, et al.
Journal of Medicinal Chemistry
|
November 18, 2022
JDQ443, a Structurally Novel, Pyrazole-Based, Covalent Inhibitor of KRAS<sup>G12C</sup> for the Treatment of Solid Tumors
Edwige Lorthiois, Marc Gerspacher, Kim S Beyer, et al.
Journal of Medicinal Chemistry
|
September 15, 2020
Discovery of Roblitinib (FGF401) as a Reversible-Covalent Inhibitor of the Kinase Activity of Fibroblast Growth Factor Receptor 4
Robin A Fairhurst, Thomas Knoepfel, Nicole Buschmann, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 10) with videos related to
Sort By:
Page
of 1
Journal of Chemical Information and Modeling
|
April 6, 2005
2D-3D migration of large chemical inventories with conformational multiplication. Application of the genetic algorithm
Ovanes Mekenyan, Todor Pavlov, Vanjo Grancharov, et al.
Journal of Chemical Information and Modeling
|
May 1, 2007
Conformational coverage by a genetic algorithm: saturation of conformational space
Todor Pavlov, Milen Todorov, Galina Stoyanova, et al.
Chemical Research in Toxicology
|
December 7, 2007
Identifying the structural requirements for chromosomal aberration by incorporating molecular flexibility and metabolic activation of chemicals
Ovanes Mekenyan, Milen Todorov, Rossitsa Serafimova, et al.
Chemical Research in Toxicology
|
September 18, 2010
Use of genotoxicity information in the development of integrated testing strategies (ITS) for skin sensitization
Ovanes Mekenyan, Grace Patlewicz, Gergana Dimitrova, et al.
Toxicology in Vitro : an International Journal Published in Association with BIBRA
|
October 12, 2010
Development of a mechanistic SAR model for the detection of phototoxic chemicals and use in an integrated testing strategy
Stephanie Ringeissen, Laurent Marrot, Reine Note, et al.
Regulatory Toxicology and Pharmacology : RTP
|
March 21, 2015
A feasibility study: Can information collected to classify for mutagenicity be informative in predicting carcinogenicity?
Petko I Petkov, Grace Patlewicz, Terry W Schultz, et al.
Journal of Applied Toxicology : JAT
|
May 27, 2016
Integrated approach to testing and assessment for predicting rodent genotoxic carcinogenicity
Petko I Petkov, Terry W Schultz, E Maria Donner, et al.
Bioorganic & Medicinal Chemistry Letters
|
September 16, 2018
In vitro and in vivo characterization of a novel, highly potent p53-MDM2 inhibitor
Andrea Vaupel, Philipp Holzer, Stephane Ferretti, et al.
Journal of Medicinal Chemistry
|
November 18, 2022
JDQ443, a Structurally Novel, Pyrazole-Based, Covalent Inhibitor of KRAS<sup>G12C</sup> for the Treatment of Solid Tumors
Edwige Lorthiois, Marc Gerspacher, Kim S Beyer, et al.
Journal of Medicinal Chemistry
|
September 15, 2020
Discovery of Roblitinib (FGF401) as a Reversible-Covalent Inhibitor of the Kinase Activity of Fibroblast Growth Factor Receptor 4
Robin A Fairhurst, Thomas Knoepfel, Nicole Buschmann, et al.
Page
of 1